Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 CAD | -3.85% | +0.57% | -29.15% |
Sales 2024 * | 154M 113M 9.38B | Sales 2025 * | 155M 113M 9.4B | Capitalization | 42.8M 31.21M 2.6B |
---|---|---|---|---|---|
Net income 2024 * | -1M -729K -60.83M | Net income 2025 * | 1M 729K 60.83M | EV / Sales 2024 * | 0.28 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.28 x |
P/E ratio 2024 * |
-24.5
x | P/E ratio 2025 * |
11.5
x | Employees | 98 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.04% |
Latest transcript on Medexus Pharmaceuticals Inc.
1 day | -3.85% | ||
1 week | +0.57% | ||
Current month | -3.85% | ||
1 month | +8.70% | ||
3 months | -25.21% | ||
6 months | -13.37% | ||
Current year | -29.15% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 16/18/16 | |
Marcel Konrad
DFI | Director of Finance/CFO | 49 | 19/21/19 |
Richard Labelle
COO | Chief Operating Officer | - | 18/14/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 25/19/25 |
Michael Mueller
CHM | Chairman | 64 | 31/14/31 |
Benoit Gravel
BRD | Director/Board Member | - | 22/17/22 |
Date | Price | Change | Volume |
---|---|---|---|
01/24/01 | 1.75 | -3.85% | 42,535 |
30/24/30 | 1.82 | -3.70% | 13,600 |
29/24/29 | 1.89 | -1.56% | 51,083 |
26/24/26 | 1.92 | +3.23% | 32,538 |
25/24/25 | 1.86 | +6.90% | 47,421 |
Delayed Quote Toronto S.E., May 02, 2024 at 01:29 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.15% | 31.11M | |
+33.25% | 699B | |
+25.50% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+15.57% | 236B | |
+5.41% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- MDP Stock